{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:12:07Z","timestamp":1792588327612,"version":"4.5.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T00:00:00Z","timestamp":1429488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123072","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T18:37:56Z","timestamp":1429555076000},"page":"e0123072","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Hepcidin-25 in Diabetic Chronic Kidney Disease Is Predictive for Mortality and Progression to End Stage Renal Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Martin","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien R.","family":"Ashby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Busbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Raff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter U.","family":"Heuschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,20]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1523-1755.2005.00226.x","article-title":"Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program","volume":"67","author":"TM El-Achkar","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1523-1755.2004.00863.x","article-title":"Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy","volume":"66","author":"A Mohanram","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"ref3","first-page":"3403","article-title":"Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease","volume":"16","author":"PT Vlagopoulos","year":"2005","journal-title":"JAmSocNephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"916560","DOI":"10.1155\/2012\/916560","article-title":"Regenerative therapies for diabetic microangiopathy","volume":"2012","author":"R Bassi","year":"2012","journal-title":"Experimental diabetes research"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"G Weiss","year":"2005","journal-title":"NEnglJMed"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1440-1681.2006.04474.x","article-title":"Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression","volume":"33","author":"C Stockmann","year":"2006","journal-title":"Clinical and experimental pharmacology & physiology"},{"key":"ref7","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney IntSuppl"},{"issue":"Suppl 3","key":"ref8","first-page":"66","article-title":"Diabetic nephropathy and anaemia","volume":"35","author":"E Ritz","year":"2005","journal-title":"EurJClinInvest"},{"issue":"2","key":"ref9","first-page":"193","article-title":"Anaemia of chronic disease","volume":"13","author":"J Cullis","year":"2013","journal-title":"ClinMed"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease","volume":"80","author":"RT Means Jr.","year":"1992","journal-title":"Blood"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.2007.06502.x","article-title":"Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers","volume":"136","author":"L Ferrucci","year":"2007","journal-title":"BrJ Haematol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jdiacomp.2005.08.001","article-title":"Anemia and the role of erythropoietin in diabetes","volume":"20","author":"JB McGill","year":"2006","journal-title":"J Diabetes Complications"},{"issue":"5","key":"ref13","first-page":"502","article-title":"Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia","volume":"23","author":"MC Thomas","year":"2006","journal-title":"DiabetMed"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1681\/ASN.2006070802","article-title":"Molecular control of iron transport. Journal of the American Society of Nephrology","volume":"18","author":"T Ganz","year":"2007","journal-title":"JASN"},{"issue":"6","key":"ref15","first-page":"2337","article-title":"Iron regulation by hepcidin","volume":"123","author":"N Zhao","year":"2013","journal-title":"JClinInvest"},{"issue":"2\u20133","key":"ref16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000243791","article-title":"The role of hepcidin in iron metabolism","volume":"122","author":"E Nemeth","year":"2009","journal-title":"Acta Haematol"},{"issue":"5704","key":"ref17","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"E Nemeth","year":"2004","journal-title":"Science"},{"issue":"17","key":"ref18","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1182\/blood-2011-01-258467","article-title":"Hepcidin and iron regulation, 10 years later","volume":"117","author":"T Ganz","year":"2011","journal-title":"Blood"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/ndt\/gft330","article-title":"Hepcidin\u2014a well-known iron biomarker with prognostic implications in chronic kidney disease","volume":"28","author":"M Wagner","year":"2013","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3899\/jrheum.110339","article-title":"Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis","volume":"38","author":"MA Abdel-Khalek","year":"2011","journal-title":"JRheumatol"},{"issue":"12","key":"ref21","first-page":"4378","article-title":"Serum hepcidin-25 levels predict the progression of renal anemia in patients with non-dialysis chronic kidney disease","volume":"27","author":"K Niihata","year":"2012","journal-title":"NephrolDialTransplant"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfs488","article-title":"Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients","volume":"28","author":"NC van der Weerd","year":"2013","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"7","key":"ref23","first-page":"1573","article-title":"Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease","volume":"6","author":"M Wagner","year":"2011","journal-title":"ClinJAmSocNephrol"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann InternMed"},{"issue":"18","key":"ref25","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"K Matsushita","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/09674845.2009.11730263","article-title":"Development of a novel immunoassay for the iron regulatory peptide hepcidin","volume":"66","author":"M Busbridge","year":"2009","journal-title":"British journal of biomedical science"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/clinchem\/44.1.45","article-title":"Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations","volume":"44","author":"AE Mast","year":"1998","journal-title":"Clin Chem"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1002\/0471725153","article-title":"Regression Diagnostics: Identifying Influential Data and Sources of Collinearity","author":"DA Belesley","year":"1980"},{"key":"ref29","article-title":"SAS System for Regression","author":"RJaL Freund","year":"2000"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.0409808102","article-title":"Regulation of hepcidin transcription by interleukin-1 and interleukin-6","volume":"102","author":"P Lee","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"E Nemeth","year":"2004","journal-title":"JClin Invest"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood-2006-10-051755","article-title":"Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation","volume":"109","author":"CN Roy","year":"2007","journal-title":"Blood"},{"issue":"7","key":"ref33","first-page":"1037","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"G Nicolas","year":"2002","journal-title":"JClinInvest"},{"key":"ref34","first-page":"347","article-title":"Hepcidin and disorders of iron metabolism","volume":"62","author":"T Ganz","year":"2011","journal-title":"AnnuRevMed"},{"issue":"10","key":"ref35","first-page":"3092","article-title":"Hepcidin: another culprit for complications in patients with chronic kidney disease?","volume":"26","author":"T Nakanishi","year":"2011","journal-title":"NephrolDialTransplant"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"T Ganz","year":"2008","journal-title":"Blood"},{"issue":"12","key":"ref37","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type 2 diabetes","volume":"363","author":"SD Solomon","year":"2010","journal-title":"NEnglJMed"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3324\/haematol.2009.013136","article-title":"Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin","volume":"95","author":"DR Ashby","year":"2010","journal-title":"Haematologica"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"DR Ashby","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"ref40","first-page":"352","article-title":"C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3\u20135 patients","volume":"67","author":"S Soriano","year":"2007","journal-title":"ClinNephrol"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1681\/ASN.2013050518","article-title":"Role of podocyte B7-1 in diabetic nephropathy","volume":"25","author":"P Fiorina","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. Journal of the American Society of Nephrology","volume":"23","author":"MA Niewczas","year":"2012","journal-title":"JASN"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"e84587","DOI":"10.1371\/journal.pone.0084587","article-title":"Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST)","volume":"9","author":"IM Mostovaya","year":"2014","journal-title":"PloS one"},{"issue":"15","key":"ref44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"N Tangri","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"ref45","first-page":"112","article-title":"The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease","volume":"18","author":"L Wang","year":"2012","journal-title":"InflammBowelDis"},{"issue":"4","key":"ref46","first-page":"431","article-title":"Prolyl hydroxylases and therapeutics","volume":"12","author":"TG Smith","year":"2010","journal-title":"AntioxidRedoxSignal"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.semnephrol.2012.07.006","article-title":"Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?","volume":"32","author":"A Doria","year":"2012","journal-title":"Seminars in nephrology"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ki.2010.254","article-title":"Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients","volume":"78","author":"BA Ford","year":"2010","journal-title":"Kidney international"},{"issue":"10","key":"ref49","first-page":"3923","article-title":"Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA","volume":"27","author":"HP Peters","year":"2012","journal-title":"NephrolDialTransplant"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T03:23:19Z","timestamp":1598930599000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123072"}},"subtitle":[],"editor":[{"given":"Paolo","family":"Fiorina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,20]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123072","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,20]]}}}